Clinical Evaluation of a Novel and Mobile Autism Risk Assessment.
Clinical Evaluation of a Novel and Mobile Autism Risk Assessment.
复制标题
DOI：
10.1007/s10803-016-2718-4
复制
发表时间：
2016-06
影响因子：
3.9
通讯作者：
Wall DP
中科院分区：
文献类型：
--
作者：
Duda M;Daniels J;Wall DP
移动的自闭症风险评估（MARA）是一种新的，电子管理的，7个问题的自闭症谱系障碍（ASD）屏幕，以分流那些最高风险的ASD。16个月至17岁的儿童（N = 222）在他们的第一次访问期间在发育行为儿科诊所进行筛选。将MARA评分与临床诊断进行比较。参与者的中位年龄为5.8岁，76.1%为男性，大多数参与者的智力/发育商数得分>85; 69名参与者（31%）接受了ASD的临床诊断。MARA诊断ASD的敏感性为89.9%[95%CI = 82.7-97]，特异性为79.7%[95%CI = 73.4-86.1].在高风险的临床环境中，MARA显示出将ASD与其他发育/行为障碍区分开来的前景。
The Mobile Autism Risk Assessment (MARA) is a new, electronically administered, 7-question autism spectrum disorder (ASD) screen to triage those at highest risk for ASD. Children 16 months–17 years (N = 222) were screened during their first visit in a developmental-behavioral pediatric clinic. MARA scores were compared to diagnosis from the clinical encounter. Participant median age was 5.8 years, 76.1 % were male, and most participants had an intelligence/developmental quotient score >85; 69 of the participants (31 %) received a clinical diagnosis of ASD. The sensitivity of the MARA in detecting ASD was 89.9 % [95 % CI = 82.7–97]; the specificity was 79.7 % [95 % CI = 73.4–86.1]. In a high-risk clinical setting, the MARA shows promise as a screen to distinguish ASD from other developmental/behavioral disorders.